Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
N/A
-9,837 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
N/A
4,800 Added 95.29%
9,837 $21,000
Q1 2021

May 17, 2021

SELL
N/A
-4,127 Reduced 45.03%
5,037 $15,000
Q4 2020

Feb 16, 2021

SELL
N/A
-8,398 Reduced 47.82%
9,164 $20,000
Q3 2020

Nov 16, 2020

BUY
N/A
2,340 Added 15.37%
17,562 $109,000
Q2 2020

Aug 13, 2020

BUY
N/A
15,222 New
15,222 $98,000
Q1 2020

May 15, 2020

SELL
N/A
-181 Closed
0 $0
Q4 2019

Feb 07, 2020

BUY
N/A
181 New
181 $1,000
Q3 2019

Nov 05, 2019

SELL
N/A
-709 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
N/A
609 Added 609.0%
709 $6,000
Q4 2018

Feb 14, 2019

BUY
N/A
100 New
100 $0

About Catabasis Pharmaceuticals, Inc.


  • Ticker CATB
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,948,800
  • Market Cap $657M
More about CATB
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.